1. Ali AM, Buji MA, Abubakar A. Patterns of computed tomographic findings in patients from Maiduguri, Nigeria, diagnosed with a brain tumor. Glioma. 2:153–156. 2019.
2. Arora RS, Alston RD, Eden TO, Estlin EJ, Moran A, Birch JM. Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England. Neuro Oncol. 11:403–413. 2009.
3. Chikani MC, Okpara S, Mathew M, Onuh A, Okwor V, Mezue W. Preliminary findings on metastatic brain tumors in Enugu, Southeast Nigeria. Niger J Med. 29:466–470. 2020.
4. Das A, Chapman CA, Yap WM. Histological subtypes of symptomatic central nervous system tumours in Singapore. J Neurol Neurosurg Psychiatry. 68:372–374. 2000.
5. Davis FG, McCarthy BJ. Current epidemiological trends and surveillance issues in brain tumors. Expert Rev Anticancer Ther. 1:395–401. 2001.
6. DeAngelis LM. Brain tumors. N Engl J Med. 334:114–123. 2001.
7. Dhar A, Bhat AR, Nizami FA, Kirmani AR, Zargar J, Ramzan AU, et al. Analysis of brain tumors in Kashmir Valley - a 10 year study. Bangladesh J Med Sci. 13:268–277. 2014.
8. Ekpene U, Ametefe M, Akoto H, Bankah P, Totimeh T, Wepeba G, et al. Pattern of intracranial tumours in a tertiary hospital in Ghana. Ghana Med J. 52:79–83. 2018.
10. Ghanghoria S, Mehar R, Kulkarni C, Mittal M, Yadav A, Patidar H. Retrospective histological analysis of CNS tumors - a 5 year study. Int J Med Sci Public Health. 3:1205–1207. 2014.
11. Grimes CE, Bowman KG, Dodgion CM, Lavy CB. Systematic review of barriers to surgical care in low-income and middle-income countries. World J Surg. 35:941–950. 2011.
12. Hewedi I, Ibrahim R, Elserry T, Taha N, Mohamed H. Frequency of primary central nervous system tumors in a tertiary hospital, Cairo, Egypt. J Community Health Manag. 5:140–146. 2018.
13. Idowu O, Akang E, Malomo A. Symptomatic primary intracranial neoplasms in Nigeria, West Africa. J Neurol Sci Turk. 24:212–218. 2017.
14. Jalali R, Datta D. Prospective analysis of incidence of central nervous tumors presenting in a tertiary cancer hospital from India. J Neurooncol. 87:111–114. 2008.
15. Jamal S, Moghal S, Mamoon N, Mushtaq S, Luqman M, Anwar M. The pattern of malignant tumours: tumour registry data analysis, AFIP, Rawalpindi, Pakistan (1992-2001). J Pak Med Assoc. 56:359–362. 2006.
16. Jibrin P, Ibebuike K, Ado-Wanka AN. Histo-pathological pattern of intracranial tumours in the National Hospital, Abuja. Afr Health Sci. 18:281–286. 2018.
17. Kleihues P, Cavenee W. Tumours of the nervous system: World Health Organization classification of tumours. France: IARC Press;2000.
18. Kolo ES, Hassan I, Ibrahim M, Misbahu AH, Adamu A, Ismail NJ, et al. Early outcome of endoscopic trans-nasal trans-sphenoidal pituitary surgery in Kano, Nigeria. Niger J Basic Clin Sci. 17:145–50. 2020.
19. Lee CH, Jung KW, Yoo H, Park S, Lee SH. Epidemiology of primary brain and central nervous system tumors in Korea. J Korean Neurosurg Soc. 48:145–152. 2010.
20. Leece R, Xu J, Ostrom QT, Chen Y, Kruchko C, Barnholtz-Sloan JS. Global incidence of malignant brain and other central nervous system tumors by histology, 2003-2007. Neuro Oncol. 19:1553–1564. 2017.
21. Louis DN. World Health Organization International Agency for Research on Cancer. 4th ed. Lyon: International Agency for Research on Cancer;2007. p. 309.
22. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131:803–820. 2016.
23. Mahmud MR, Idris MM. A glance at neurosurgery in Nigeria following the 3rd CAANS congress. AANS Neurosurgeon. 27:2018.
24. Masoodi T, Gupta RK, Singh JP, Khajuria A. Pattern of central nervous system neoplasms: a study of 106 cases. JK Pract. 17:42–46. 2012.
25. McKinney PA. Brain tumours: incidence, survival, and aetiology. J Neurol Neurosurg Psychiatry. 75 Suppl 2(Suppl 2):ii12–ii17. 2004.
26. Mehta J, Bansal B, Mittal A, Mathur K, Vijay R. Histological analysis of primary brain tumors in a tertiary care hospital: a retrospective study of 5 years. Int J Med Res Prof. 3:14–18. 2017.
27. Mondal S, Pradhan R, Pal S, Biswas B, Banerjee A, Bhattacharyya D. Clinicopathological pattern of brain tumors: a 3-year study in a tertiary care hospital in India. Clin Cancer Investig J. 5:437. 2016.
29. Ohaegbulam SC, Saddeqi N, Ikerionwu S. Intracranial tumors in Enugu, Nigeria. Cancer. 46:2322–2324. 1980.
30. Olasode BJ, Shokunbi MT, Aghadiuno PU. Intracranial neoplasms in Ibadan, Nigeria. East Afr Med J. 77:4–8. 2000.
31. Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol. 17 Suppl 4(Suppl 4):iv1–iv62. 2015.
32. Salander P, Bergenheim AT, Hamberg K, Henriksson R. Pathways from symptoms to medical care: a descriptive study of symptom development and obstacles to early diagnosis in brain tumour patients. Fam Pract. 16:143–148. 1999.
33. Soyemi SS, Oyewole OO. Spectrum of intracranial tumours in a tertiary health carefacility: our findings. Pan Afr Med J. 20:24. 2015.
34. Stewart BW, Kleihues P. Tumours of the Nervous System. Lyon: IARC;2003. p. 265–269.
35. Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol. 1:14–25. 1999.
36. Tuly TI. Pattern of Brain Tumour among Admitted Patients in a Specialized Center of Dhaka City: A Cross Sectional Study. Available at :
http://hdl.handle.net/10361/9327.
37. Uche EO, Emejulu JKC, Okorie E, Onyia EE, Iloabachie I, Uche N, et al. Brain astrocytomas in South-East Nigeria: a 3-centre experience. J Clin Appl Neurosci. 1:37–43. 2015.
38. World Health Organization. Cancer Incidence in Five Continents. Available at :
http://ci5.iarc.fr.
39. Yeole BB. Trends in the brain cancer incidence in India. Asian Pac J Cancer Prev. 9:267–270. 2008.